Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.73% |
| 2 | Technology | 20.55% |
| 3 | Financials | 7.82% |
| 4 | Consumer Discretionary | 7.64% |
| 5 | Communication Services | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5126
Ovid Therapeutics
OVID
$414M
| $3.77K | ﹤0.01% |
11,411
-31,786
| -74% | -$9.58K |
2023 Q2
8 quarters
|
|
5127
ALX Oncology
ALXO
$152M
| $3.74K | ﹤0.01% |
9,010
-15,701
| -64% | -$7.92K |
2020 Q3
19 quarters
|
|
5128
Gauzy
GAUZ
$5.26M
| $3.73K | ﹤0.01% |
22
+3
| +16% | +$531 |
2024 Q4
2 quarters
|
|
5129
Acumen Pharmaceuticals
ABOS
$121M
| $3.61K | ﹤0.01% |
3,115
-26,721
| -90% | -$28.7K |
2021 Q3
15 quarters
|
|
5130
SES AI
SES
$282M
| $3.6K | ﹤0.01% |
4,054
-91,565
| -96% | -$76.8K |
2022 Q1
13 quarters
|
|
5131
GeoVax Labs
GOVX
$2.19M
| $3.55K | ﹤0.01% |
+164
| New | +$4.09K |
2025 Q2
0 quarters
|
|
5132
Pluri
PLUR
$11.7M
| $3.52K | ﹤0.01% |
+712
| New | +$3.29K |
2025 Q2
0 quarters
|
|
5133
ATRenew
RERE
$864M
| $3.41K | ﹤0.01% |
1,031
| – | – |
2021 Q4
14 quarters
|
|
5134
CBAK Energy Technology Ltd
CBAT
$95.7M
| $3.35K | ﹤0.01% |
+2,843
| New | +$2.56K |
2025 Q2
0 quarters
|
|
5135
Nautilus Biotechnolgy
NAUT
$274M
| $3.34K | ﹤0.01% |
4,613
-29,140
| -86% | -$21.9K |
2021 Q1
17 quarters
|
|
5136
China Yuchai International
CYD
$986M
| $3.32K | ﹤0.01% |
+139
| New | +$2.44K |
2025 Q2
0 quarters
|
|
5137
DELISTED
Generation Bio
GBIO
| $3.32K | ﹤0.01% |
1,036
-2,443
| -70% | -$9.41K |
2020 Q3
19 quarters
|
|
5138
Schwab Fundamental International Small Company Index ETF
FNDC
$3.06B
| $3.28K | ﹤0.01% |
78
| – | – |
2021 Q2
16 quarters
|
|
5139
Blink Charging
BLNK
$63.1M
| $3.21K | ﹤0.01% |
3,413
-74,508
| -96% | -$59.5K |
2020 Q3
19 quarters
|
|
|
QIPT
5140
DELISTED
Quipt Home Medical
QIPT
| $3.2K | ﹤0.01% |
1,792
-24,668
| -93% | -$48.7K |
2023 Q1
9 quarters
|
|
5141
Sportsman's Warehouse
SPWH
$41.9M
| $3.05K | ﹤0.01% |
+885
| New | +$1.98K |
2025 Q2
0 quarters
|
|
|
VSEE
5142
DELISTED
VSEE HEALTH INC
VSEE
| $2.89K | ﹤0.01% |
+2,489
| New | +$2.85K |
2025 Q2
0 quarters
|
|
|
ABPWW
5143
CALL
DELISTED
Abpro Holdings Warrant
ABPWW
| $2.88K | ﹤0.01% |
125,001
| – | – |
2022 Q1
13 quarters
|
|
5144
Genprex
GNPX
$1.78M
| $2.87K | ﹤0.01% |
+11
| New | +$3.36K |
2025 Q2
0 quarters
|
|
5145
Telefônica Brasil
VIV
$19.8B
| $2.87K | ﹤0.01% |
252
-43,522
| -99% | -$428K |
2013 Q2
48 quarters
|
|
5146
Acquirers Small and Micro Deep Value ETF
DEEP
$28M
| $2.83K | ﹤0.01% |
+86
| New | +$2.65K |
2025 Q2
0 quarters
|
|
5147
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.34B
| $2.73K | ﹤0.01% |
28
+26
| +1,300% | +$2.49K |
2013 Q2
48 quarters
|
|
5148
Q32 Bio
QTTB
$221M
| $2.71K | ﹤0.01% |
1,822
-2,580
| -59% | -$4.4K |
2024 Q2
4 quarters
|
|
5149
MINISO
MNSO
$2.99B
| $2.7K | ﹤0.01% |
148
-137
| -48% | -$2.46K |
2023 Q1
9 quarters
|
|
5150
Immuneering
IMRX
$234M
| $2.68K | ﹤0.01% |
796
| – | – |
2021 Q3
15 quarters
|
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2025 filing shows 467 new, 1,653 increased, 2,974 reduced and 377 closed positions. Its largest new stake was Amrize Ltd: 2,294,135 shares worth $114M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $625M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 467 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.